Understanding Bioequivalence: Why Generic Substitute Finders Work

A generic tablet costs a fraction of the branded one because the manufacturer skipped the R&D cost, not the manufacturing standard. The regulator's word for 'chemically identical AND absorbed the same way' is bioequivalent, and it is the single most important word in a conversation about substitutes. If a generic is bioequivalent to a branded drug, they are — clinically — the same medicine.

What CDSCO actually requires

The Central Drugs Standard Control Organisation, the Indian equivalent of the US FDA, requires a generic manufacturer to prove:

• The same active ingredient, at the same strength.
• The same dosage form (tablet, capsule, syrup).
• The same route of administration (oral, IV, topical).
• Bioequivalence demonstrated in trials at CDSCO-approved sites.

Bioequivalence itself has a specific technical definition: the 90% confidence interval for the ratio of absorption (Cmax and AUC) between the test and reference product must fall between 80% and 125%. That range sounds wide but is deliberately conservative — most well-manufactured generics fall inside a much tighter band around the reference.

What a generic is NOT allowed to differ on

• Property: Active ingredient · Must match reference: Yes · May differ: —
• Property: Strength · Must match reference: Yes · May differ: —
• Property: Dosage form · Must match reference: Yes · May differ: —
• Property: Absorption profile · Must match reference: Yes (within ±20-25%) · May differ: —
• Property: Inactive ingredients · Must match reference: — · May differ: Colours, coatings, binders
• Property: Shape and colour of tablet · Must match reference: — · May differ: Can be different
• Property: Brand name · Must match reference: — · May differ: By definition

Why the different inactive ingredients rarely matter

The commonest reason people distrust generics is that a substituted tablet looks different. It is a different colour, a different shape, sometimes tastes different. The chemistry of that is: the fillers, coatings and dyes are different, but they are chosen from the same short list of pharmacologically inert substances the branded version also uses. The active molecule is the same amount doing the same thing.

A rare exception matters: an inactive ingredient a specific patient is allergic to. Somebody with a lactose intolerance might react to a generic that uses lactose as a filler where the branded one uses cellulose. This is a real but small consideration, and it is why the substitution conversation should include the pharmacist.

Where extra caution is genuinely warranted

For most drugs the substitution is straightforward. For a narrow set of medicines with a narrow therapeutic index — the range between an effective dose and a toxic one is small — small differences in absorption matter more:

• Warfarin — anticoagulation
• Phenytoin, carbamazepine, valproate — anti-seizure
• Lithium — psychiatric
• Levothyroxine — thyroid
• Cyclosporin, tacrolimus — transplant

For these, keeping the same brand is the safer default, and any switch should be discussed with the treating doctor and monitored with the appropriate blood level test.

References

• CDSCO — Bioavailability / Bioequivalence guidelines
• Diligence Certification — CDSCO Bioequivalence Testing in India
• IMSDA — how CDSCO ensures the quality of generic medicines
• Wiley — BA/BE studies patterns in the US, EU and India